Cost-effectiveness of Shared Telemedicine Appointments in Young Adults With T1D: CoYoT1 Trial
Author(s) -
Wen Wan,
Aviva G. Nathan,
M. Reza Skandari,
Parmida Zarei,
Mark W. Reid,
Jennifer K. Raymond,
Elbert S. Huang
Publication year - 2019
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc19-0363
Subject(s) - medicine , telehealth , glycemic , telemedicine , randomized controlled trial , quality of life (healthcare) , young adult , intervention (counseling) , significant difference , physical therapy , diabetes mellitus , family medicine , gerontology , pediatrics , health care , nursing , economic growth , endocrinology , economics
Within the trial, we found no significant differences in 9-month quality-adjusted life; however, the control group had a larger decline from baseline in utility than the CoYoT1 group, indicating a quality of life (QoL) benefit of the intervention (difference in difference mean ± SD: 0.04 ± 0.09; = 0.03). CONCLUSIONS: The CoYoT1 care model may help YAs with T1D maintain a higher QoL with no increase in costs.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom